|
Pediatric Hypothalamic Obesity Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Pediatric Hypothalamic Obesity conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Pediatric Hypothalamic Obesity Clinical research trials and Pediatric Hypothalamic Obesity health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Pediatric Hypothalamic Obesity. Pediatric Hypothalamic Obesity Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Pediatric Hypothalamic Obesity clinical trial. Participants oftentimes recieve the most expert healthcare available for their Pediatric Hypothalamic Obesity condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pediatric Hypothalamic Obesity  Pediatric Hypothalamic Obesity
Pediatric Hypothalamic Obesity
For Condition: Obesity
Status: Not yet recruiting
Sponsor(s): Novartis Pharmaceuticals ,
Synopsis: This trial is being conducted in pediatric patients with Hypothalamic Obesity. This generally occurs in people who have had an injury to or tumor in their hypothalamus (gland or organ that secretes hormones). The purpose of this trial is to see how an investigational treatment controls the hormone insulin by lowering the level of insulin in the body resulting in a weight loss in children who are at least 6 years of age but less than 18 years of age. Some children in this trial will receive placebo. To qualify for this study, you and your child’s doctor must feel that your child’s weight is inadequately controlled within a year from the time of injury to the hypothalamus or tumor of the hypothalamus. This study will help to determine if an investigational treatment is of benefit in controlling a child’s weight.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 6 Years/18 Years
Genders: Both
Protocol Entry Criteria: - Male and female patients ages 6 to less than 18 - Patients who have experienced any form of cranial insult related to cranial trauma, or to a tumor or it’s treatment (i.e. surgery, radiation, and/or chemotherapy) - Patients who are at least one year out following therapy for their tumor - Patients who have severe cardiovascular dysfunction (for example cardiomyopathy, congestive heart failure (NYHA Class III or IV), unstable angina, sustained ventricular tachycardia, ventricular fibrillation) will be excluded - Patients with severe neurologic handicaps which preclude normal physical activity will be excluded. - Patients confined to bed and those patients who are wheelchair bound which prevents them from activities of daily living or normal physical activity, i.e. walking, will be excluded from the trial - Your child must be greater than 120% of their ideal body weight for their height or have a body mass index that is greater than or equal to 27.
Total Enrollment: 50
Location and Contact Information:
Additional Information:
Study ID Numbers: CSMS995B2403;
Study Start Date: March 2004
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00076362
Other Obesity Studies:
1. National Heart, Lung, and Blood Institute Twin Study
2. Computer Intervention for Prevention of Weight Regain
3. Divergence of Blood Pressure By Race in Adolescent Girls
4. Obese Patients with Type 2 Diabetes
5. Cardiovascular Disease Mortality in The NAS-NRC Twin Registry
Related Studies:
Other Obesity Clinical Trials
Other Clinical Trials
Other Clinical Trials
Pediatric Hypothalamic Obesity
|
|
|
|
|
|
|
|
